Burning Rock Biotech Ltd (BNR) › Shareholders' EquityBurning Rock Biotech Ltd (BNR) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -372.16M CNY2018: -603.46M CNY2019: -891.49M CNY2020: 2.42B CNY2021: 1.85B CNY2022: 1.16B CNY2023: 768.41M CNY2024: 580.83M CNY2025: 535.26M CNY535.26M CNY2017Shareholders' Equity (CNY)2025Fiscal YearShareholders' EquityChange YoY2025535.26M CNY-7.8%2024580.83M CNY-24.4%2023768.41M CNY-33.7%20221.16B CNY-37.2%20211.85B CNY-23.8%20202.42B CNY+371.6%2019-891.49M CNY-47.7%2018-603.46M CNY-62.2%2017-372.16M CNY—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share